Publication date: Jun 21, 2026
COVID-19 has been linked to broad post-acute sequelae, but delayed micronutrient deficiency remains insufficiently characterized. Whether COVID-19 increases long-term risks of laboratory-defined vitamin D, magnesium, and vitamin B12 deficiencies among patients with type 2 diabetes mellitus is unclear. Using the predominantly US-based TriNetX network, we identified adults with type 2 diabetes mellitus (T2DM) during 2020-2022 who had COVID-19 and matched controls without COVID-19. A 12-month landmark design excluded pre-existing deficiencies, skeletal outcomes, and early deaths. After 1:1 propensity score matching, Cox models estimated hazard ratios (HRs) for incident deficiencies and skeletal outcomes over an up-to-5-year analytic window, with tested-cohort, severity-gradient, competing-risk, and E-value analyses. After matching, 645,168 patients remained per group. COVID-19 was associated with higher risks of vitamin D deficiency (HR, 1. 79), magnesium deficiency (HR, 1. 77), vitamin B12 deficiency (HR, 1. 56), osteoporosis (HR, 1. 55), osteoporotic fracture (HR, 1. 73), femur fracture (HR, 1. 58), and death (HR, 1. 59; all p
Open Access PDF
| Concepts | Keywords |
|---|---|
| COVID-19 | |
| magnesium deficiency | |
| SARS-CoV-2 | |
| type 2 diabetes mellitus | |
| vitamin B12 deficiency | |
| vitamin D deficiency |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | type 2 diabetes |
| drug | DRUGBANK | Vitamin D |
| drug | DRUGBANK | Magnesium |
| disease | MESH | vitamin B12 deficiencies |
| disease | MESH | HRs |
| drug | DRUGBANK | Flunarizine |
| disease | MESH | vitamin D deficiency |
| disease | MESH | magnesium deficiency |
| disease | MESH | osteoporosis |
| disease | MESH | osteoporotic fracture |
| disease | MESH | death |
| drug | DRUGBANK | Coenzyme M |
| pathway | REACTOME | Reproduction |
| disease | MESH | diabetes mellitus |
| disease | MESH | vitamin deficiency |